Nonambulatory People With MS Don't Fare Well With COVID-19
Certain risk factors are associated with a worse COVID-19 outcome among people with MS, according to data collected by COViMS.
Stay updated with breaking news from Amber Salter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Certain risk factors are associated with a worse COVID-19 outcome among people with MS, according to data collected by COViMS.
Despite sweeping regulatory changes, usage of cannabis by patients with multiple sclerosis remains relatively steady, especially for treating spasticity, new research shows.
Disability and age were associated with poorer COVID-19 outcomes in multiple sclerosis (MS) patients, registry data showed. Of approximately 2,000 people with MS and COVID-19 in North America, 17.8% of non-ambulatory patients died, compared with 4.3% of MS patients who walked with assistance and 0.6% of patients who were fully ambulatory, reported Amber Salter, PhD, of Washington University School of Medicine in St. Louis. Death occured most frequently in MS patients, ages 75 and older, who had COVID-19, she said in a presentation at ACTRIMS Forum 2021, the annual meeting of the Americas Comm...